• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Correction to "Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry".

出版信息

ACR Open Rheumatol. 2025 Aug;7(8):e70104. doi: 10.1002/acr2.70104.

DOI:10.1002/acr2.70104
PMID:40728028
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12305346/
Abstract
摘要

相似文献

1
Correction to "Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry".对“改善病情抗风湿药物治疗延迟对银屑病关节炎的影响：CorEvitas银屑病关节炎/脊柱关节炎登记研究”的勘误
ACR Open Rheumatol. 2025 Aug;7(8):e70104. doi: 10.1002/acr2.70104.
2
Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.改善病情抗风湿药物治疗延迟对银屑病关节炎的影响：CorEvitas银屑病关节炎/脊柱关节炎注册研究
ACR Open Rheumatol. 2025 Jun;7(6):e70019. doi: 10.1002/acr2.70019.
3
Does current evidence on disease-modifying antirheumatic drugs for psoriatic arthritis reinforce an effect on radiographic progression? Results from a systematic review and meta-analysis.当前关于治疗银屑病关节炎的疾病修正抗风湿药物的证据是否加强了其对放射学进展的作用？系统评价和荟萃分析的结果。
Clin Rheumatol. 2021 Sep;40(9):3499-3510. doi: 10.1007/s10067-021-05622-w. Epub 2021 Feb 12.
4
Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.生物制剂和其他疾病修正抗风湿药物对银屑病和银屑病关节炎患者心血管结局的影响：系统评价。
Curr Pharm Des. 2014;20(4):500-12. doi: 10.2174/138161282004140213123505.
5
Improvement in work productivity among psoriatic arthritis patients treated with biologic or targeted synthetic drugs: a systematic literature review and meta-analysis.生物制剂或靶向合成药物治疗银屑病关节炎患者的工作生产力改善：系统文献回顾和荟萃分析。
Arthritis Res Ther. 2024 Feb 15;26(1):50. doi: 10.1186/s13075-024-03282-0.
6
Effectiveness of treat-to-target tapering of TNF inhibitors for psoriatic arthritis and axial spondyloarthritis in the Netherlands: 24-month follow-up of the DRESS-PS trial.荷兰肿瘤坏死因子抑制剂达标减量治疗银屑病关节炎和中轴型脊柱关节炎的有效性：DRESS-PS试验的24个月随访
Lancet Rheumatol. 2025 Sep;7(9):e642-e651. doi: 10.1016/S2665-9913(25)00070-0. Epub 2025 Jul 24.
7
Combination therapy for pain management in inflammatory arthritis (rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, other spondyloarthritis).炎症性关节炎（类风湿性关节炎、强直性脊柱炎、银屑病关节炎、其他脊柱关节炎）疼痛管理的联合治疗
Cochrane Database Syst Rev. 2011 Oct 5(10):CD008886. doi: 10.1002/14651858.CD008886.pub2.
8
Effectiveness of ixekizumab in 709 real-world patients with axial spondyloarthritis and psoriatic arthritis: a nationwide cohort study.司库奇尤单抗在709例轴性脊柱关节炎和银屑病关节炎真实世界患者中的有效性：一项全国性队列研究。
RMD Open. 2025 Jul 22;11(3):e005806. doi: 10.1136/rmdopen-2025-005806.
9
Risk of infections in psoriatic arthritis or axial spondyloarthritis patients treated with targeted therapies: A meta-analysis of randomized controlled trials.靶向治疗治疗的银屑病关节炎或中轴型脊柱关节炎患者的感染风险：一项随机对照试验的荟萃分析。
Joint Bone Spine. 2024 May;91(3):105673. doi: 10.1016/j.jbspin.2023.105673. Epub 2023 Nov 30.
10
Disease-modifying antirheumatic drug-free remission in psoriatic arthritis: is it attainable and sustainable? A large longitudinal study.银屑病关节炎中无改善病情抗风湿药缓解：是否可实现及可持续？一项大型纵向研究。
Ann Rheum Dis. 2025 Jul;84(7):1130-1139. doi: 10.1016/j.ard.2025.04.022. Epub 2025 May 16.

本文引用的文献

1
Impact of Delay of Treatment With Disease-Modifying Antirheumatic Drugs in Psoriatic Arthritis: The CorEvitas Psoriatic Arthritis/Spondyloarthritis Registry.改善病情抗风湿药物治疗延迟对银屑病关节炎的影响：CorEvitas银屑病关节炎/脊柱关节炎注册研究
ACR Open Rheumatol. 2025 Jun;7(6):e70019. doi: 10.1002/acr2.70019.